Cationic Hydrogel Nanoparticles for Membrane Permeabilization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current intracellular delivery methods for membrane-impermeable molecules face challenges such as inefficient cargo decomplexation, endosomal escape, and cell viability issues, particularly in ex vivo applications where high-throughput and cost-effective techniques are needed for diverse cell types.

Innovation Solution

The use of supramolecular cationic materials, specifically crosslinked cationic hydrogel nanoparticles like dextran nanogels, which disrupt cell membranes to enable direct cytosolic delivery without interacting with the cargo, allowing for passive transport across the cell membrane.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If carrier-based delivery using non-viral nanocarriers is used, then cargo protection from degradation and scalability are improved, but cargo encapsulation is limited by physicochemical properties and endosomal escape remains inefficient

Engineering Contradiction:
Improvecargo protection from degradationVSAvoidcargo flexibility
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The invention extracts the membrane disruption function from the carrier system, using cationic polymers solely as membrane permeabilizing agents rather than as cargo carriers. This separates the membrane interaction function from the cargo delivery function, allowing any membrane-impermeable cargo to be delivered directly through polymer-induced pores without requiring cargo-specific carrier optimization.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The cationic polymer formulation serves multiple functions: it permeabilizes the membrane, enables direct cytosolic delivery, and can be applied to diverse cell types without requiring cell-specific optimization. This universal approach replaces the need for cargo-specific carrier design and endosomal escape mechanisms.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Productivity

If membrane disruption-mediated delivery is used, then flexibility and delivery efficiency are improved, but cell viability is reduced due to membrane defects and cellular stress responses

Engineering Contradiction:
Improvedelivery efficiencyVSAvoidcell viability
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The invention optimizes the concentration and properties of cationic polymers to achieve membrane permeabilization at sub-toxic levels. By carefully controlling polymer concentration and using crosslinked formulations, the system achieves efficient delivery while minimizing membrane damage and cellular stress responses that would compromise viability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The cationic polymer acts as a temporary, disposable permeabilizing agent that facilitates delivery and then dissipates, unlike viral vectors that require complex life cycle management. The polymer-induced membrane pores close after cargo delivery, restoring membrane integrity without leaving persistent damage.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Productivity

If ex vivo cell engineering is performed for extended periods, then delivery completeness is improved, but cell viability deteriorates due to culture time-related stress

Engineering Contradiction:
Improvedelivery completenessVSAvoidcell culture time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The membrane permeabilization and cargo delivery are performed as a rapid preliminary action before extended culture periods begin. The cationic polymer induces immediate membrane pore formation, allowing cargo entry within minutes, thereby completing delivery before time-related viability issues can develop during subsequent culture.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach achieves high efficiency in delivering a wide range of molecules, including large cargo, with minimal cell damage and extended incubation times, bypassing the need for external triggers and endocytic pathways, thus improving delivery efficacy and cell viability.

Implementation Method 1

The cell membrane is composed of phospholipids with negatively charged phosphate groups. Cationic materials interact electrostatically with these negative charges, disrupting membrane structure and forming transient pores that enable passive transport of cargo molecules into the cell cytosol without requiring endocytic pathways.

Methodology Applied
Scientific EffectElectrostatic interaction: Electrostatics

Implementation Method 2

Studies using supported lipid bilayers as model membranes revealed that localized membrane thinning events typically precede the complete removal of lipids, eventually resulting in membrane pores with an estimated average size of 15-40 nm in diameter. This pore formation enables passage of membrane-impermeable molecules into the cytosol.

Methodology Applied
Scientific EffectMembrane thinning and pore formation: Porosity

Data Source

PatentUS20240165261A1Means and method for cytosolic delivery
Publication Date: 2024.05.23 UNIV GENT
  • US20240165261A1 patent drawing
  • US20240165261A1 patent drawing
  • US20240165261A1 patent drawing

AI summary

The present invention is related to the field of intracellular delivery of membrane-impermeable materials. It provides compositions enabling the delivery of such membrane-impermeable materials into cells, applicable for both in vitro, in vivo and ex vivo delivery applications, as well as the use thereof in methods of cytosolic delivery of membrane-impermeable materials. The compositions and methods are particularly useful in biological research, diagnostic methods and the development of cell-based therapies.